Reproducible gene targeting in recalcitrant Escherichia coli isolates by Derous, Veerle et al.
SHORT REPORT Open Access
Reproducible gene targeting in recalcitrant
Escherichia coli isolates
Veerle Derous
1*, Francine Deboeck
1, Jean-Pierre Hernalsteens
1 and Henri De Greve
2,3
Abstract
Background: A number of allele replacement methods can be used to mutate bacterial genes. For instance, the
Red recombinase system of phage Lambda has been used very efficiently to inactivate chromosomal genes in E.
coli K-12, through recombination between regions of homology. However, this method does not work
reproducibly in some clinical E. coli isolates.
Findings: The procedure was modified by using longer homologous regions (85 bp and 500-600 bp), to inactivate
genes in the uropathogenic E. coli strain UTI89. An lrhA regulator mutant, and deletions of the lac operon as well
as the complete type 1 fimbrial gene cluster, were obtained reproducibly. The modified method is also functional
in other recalcitrant E. coli, like the avian pathogenic E. coli strain APEC1. The lrhA regulator and lac operon deletion
mutants of APEC1 were successfully constructed in the same way as the UTI89 mutants. In other avian pathogenic
E. coli strains (APEC3E, APEC11A and APEC16A) it was very difficult or impossible to construct these mutants, with
the original Red recombinase-based method, with a Red recombinase-based method using longer (85 bp)
homologous regions or with our modified protocol, using 500 - 600 bp homologous regions.
Conclusions: The method using 500-600 bp homologous regions can be used reliably in some clinical isolates, to
delete single genes or entire operons by homologous recombination. However, it does not invariably show a
greater efficiency in obtaining mutants, when compared to the original Red-mediated gene targeting method or
to the gene targeting method with 85 bp homologous regions. Therefore the length of the homology regions is
not the only limiting factor for the construction of mutants in these recalcitrant strains.
Background
The entire genomic sequences of the uropathogenic
Escherichia coli strains CFT073, UTI89 and 536 were
recently determined [1-3]. At present, functions should
be assigned to the relevant open reading frames (ORFs),
e.g. by characterizing the appropriate mutant strains.
Precise gene inactivation is an important tool in bac-
terial genetics. A number of allele replacement methods
were developed to mutate bacterial genes. An elegant
method, based on homologous recombination, mediated
by the Red system of phage Lambda, is used routinely
for the construction of deletion mutants in E. coli K-12
[4]. Pathogenic E. coli isolates are often more challen-
ging to manipulate genetically than this laboratory
strain. Here we report on the application and validation
of a modified Red-mediated gene targeting method, in
which 500-600 bp long homology regions were used to
delete reproducibly specific genes in E. coli UTI89 (see
Figure 1). This modified method allows the directed
deletion of any non-essential region - one gene or an
entire operon - in the chromosome, by substitution of
an antibiotic resistance marker, using Red-mediated
homologous recombination. Subsequently, these
mutants can easily be converted into non-polar dele-
tions. The described modified method is not only suc-
cessful in E. coli UTI89, but is also effective in other
clinical E. coli isolates, like avian pathogenic E. coli
(APEC) strains. Its efficiency was compared with the ori-
ginal Red-mediated gene targeting procedure [4] and
with another modified Red-mediated gene targeting pro-
cedure, in which longer (85 bp) homology regions were
used. * Correspondence: Veerle.Derous@vub.ac.be
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Bacterial strains, plasmids and media
The E. coli strain UTI89 (serotype O18:K1:H7) [2] [Gen-
Bank:CP000243] is a human cystitis isolate. The E. coli
strain APEC1 (serogroup O45) [5] was isolated from the
peritoneum of a broiler breeder chicken. The E. coli
strain APEC3E (serogroup O78) was isolated from the
caecum of a layer chicken and the strains APEC11A and
APEC16A (both serogroup O78) were obtained from
the heart of layer chickens [6].
The plasmids pKD3 [GenBank: AY048742] and
pKD46 [GenBank: AY048746] were described by Dat-
senko and Wanner [4]. Plasmid pDONR221 was pur-
chased from Invitrogen. The plasmid pEHEC356 [7] was
used as a control in the transformation experiments.
Bacteria were grown routinely in LB broth and on LB
agar plates [8]. The medium was supplemented with
chloramphenicol (25 μg/ml), carbenicilline (100 μg/ml)
or kanamycin (25 μg/ml) if needed.
For electroporation, salt-optimized carbon broth
(SOC) was used [9].
Phosphate Buffered Saline (PBS) was as described [10].
Modified Red-mediated gene targeting method, using
500-600 bp homology regions (see Figure 1)
Amplification and purification of DNA-fragments
Polymerase chain reactions (PCR) were carried out in an
Applied Biosystems 2720 Thermal Cycler using Ex
Takara DNA Polymerase. Annealing and elongation
temperatures were 55°C and 68°C respectively. Elonga-
tion time was 1 minute per 1000 bp. The primers used
in the PCR reactions are listed in Table 1. PCR-frag-
ments were purified using the Qiaquick PCR Purifica-
tion Kit (Qiagen). PCR products and purified PCR
fragments were analyzed by electrophoresis on 1.0%
agarose gels.
Construction of intermediate gene replacement vectors
First, two 500-600 bp homology regions (’A’ and ‘B’), sur-
rounding the targeted sequence, were amplified from total
genomic DNA of E. coli UTI89. Primers (see Table 1) are
designed in such a way that the PCR-fragments A and B
have an overlap of approximately 25-30 bp. After
Figure 1 Schematic representation of the construction of specific deletion mutants in E. coli UTI89. In the first step, homology regions A
and B, flanking the deletion, were amplified by PCR. Primers were designed in such a way that fragments were generated with an attB-site on
one side and with a restriction enzyme site and an overlap region of 25-30 bp on the other side. Overlap-PCR was subsequently carried out with
the attB-containing primers, to join regions A and B. The resulting PCR fragment was used in a BP-reaction with the pDONR221 plasmid. This
gave rise to a plasmid containing the overlap-PCR fragment. After PmeI restriction of the plasmid, the chloramphenicol resistance marker cat was
inserted. A final PCR-fragment was obtained using primers SeqLA1 and SeqLB, which are located on pDONR221. This fragment was
electroporated in arabinose-induced E. coli strains harbouring the helper plasmid pKD46 expressing the Red recombinase.
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joined by overlap-PCR, which was carried out with the two
‘outside’ primers containing the attB-sites of the Gateway
®
cloning system. The Gateway
® Technology (Invitrogen) is
a universal cloning method providing a rapid and efficient
way to move DNA sequences into multiple vector systems.
The technology is based on the site-specific recombination
system of bacteriophage lambda. This recombination
occurs between site-specific attachment (att) sites and is
catalyzed by a mixture of enzymes. The components of the
lambda recombination system were modified to improve
the specificity and efficiency of the system.
The resulting PCR-fragment comprises homology
regions A and B, flanked by attB-sites, and has a unique
Table 1 List of primers
Primer Sequence (5’ -3 ’)
SeqLA1 CTCTCGCGTTAACGCTAGCATGGAT
SeqLB GTAACATCAGAGATTTTGAGACAC
P1 GTGTAGGCTGGAGCTGCTTC
P2 CATATGAATATCCTCCTTAG
AttB1LrhA GGGGACAAGTTTGTACAAAAAAGCAGGCTTACGGCAGATGGACGCCACATCGATT
LrhAPmeI-1 AGTATGAGCCGCCAGTAAGTGATAATATATGGTTTAAACTCGACGGACGATAGATAATT
LrhAPmeI-2 ATTGTCTCAGGAATTATCTATCGTCCGTCGAGTTTAAACCATATATTATCACTTACTGGCGGCTCA
AttB2LrhA GGGGACCACTTTGTACAAGAAAGCTGGGTCTGCTCTTGATGCCGCCTCACCATT
LrhA5 CAGTGATGAGCGATGACTTCAGTG
LrhA6 TAGAAGATTACTTTGCCTAACATA
AttB1Lac GGGGACAAGTTTGTACAAAAAAGCAGGCTTACTACGGCAATGCACTCCTATAA
LacPmeI-1 TAACAATTTCACAGGATACAGCTATGGTTTAAACATAAGCAAAATTGCCTGATGCGCTCCGCTT
LacPmeI-2 AAGCGGAGCGCATCAGGCAATTTTGCTTATGTTTAAACCATAGCTGTATCCTGTGTGAAATTGTTA
AttB2Lac GGGGACCACTTTGTACAAGAAAGCTGGGTATAAATATCTC ACACGCAATCAAATTCA
LacZYA-1 TTGTTGGGGCGATTCCGCATTTTGAATTTA
LacZYA-2 GTCAGTGGGCTGATCATTAACTAT
AttB1Type1 GGGGACAAGTTTGTACAAAAAAGCAGGCTAT CTCCAGGAAATACACAGTCTGAAA
Type1PmeI-1 TACCTGCATTAGCAATGCCCTGTGA TTTCTGTTTAAACCATCGTTTTCCCTTATAATTACAGACGCGCACTA
Type1PmeI-2 TAGTG CGCGTCTGTAATTATAAGGGAAAACGATGGTTTAAACAGAAATCACAGGGCATTGCTAATGCAGGTA
AttB2Type1 GGGGACCACTTTGTACAAGAAAGCTGGGTGTACCAGCG CCAGGTCTGTTCCATGATTT
Type1-1 GAAATATGTTTCCTGGTTTTTGGCTTGTAA
Type1-2 ACGACAGACCACACCAGGCCTGCGTCTT
Type1DW1 TATTGCTAACCCAGCACAGCTAGTGCGCGTCTGTAATTATAAGGGAAAACG TTGAGCGATTGTGTAGGCTGGAGCTGCTTC
Type1DW2 GTTTTAGCTTCAGGTAATATTGCGTACCTGCATTAGCAATGCCCTGTGATTTCT TTAGCCATGGTCCATATGAATATCCTCCTTAG
LrhADW1 GTGTGCACAGCATTAACCAGCTCAGTATGAGCCGCCAGTAAGTGATAATA TGTGTAGGCTGGAGCTGCTTC
LrhADW2 CAGCGGCTCGTTTTTTACACTATTGTCTCAGGAATTATCTATCGTCCGTC CATATGAATATCCTCCTTAG
LacZDW1 GTATGTTGTGTGAAATTGTGAGCGAATAACAATTTCACACAGGATACAGCT TTGAGCGATTGTGTAGGCTGGAGCTGCTTC
LacZDW2 TGAAATTGTAGGCCTGATAAGCGGAGCGCATCAGGCAATTTTGCTTATTTA TTAGCCATGGTCCATATGAATATCCTCCTTAG
Type1DWL1 CGTAAGCTGACGAATCAGCAGGAATAATCGCTAGGGACCTAAGAATTAGCATGATAATAGCCACTAAGAAATTACTGCGC
TCCATGTGTAGGCTGGAGCTGCTTC
Type1DWL2 TTATCTGGCCTACAAAGGGCTAACGTGCAGGTTTTTAGCTTCAGGTAATATTGCGTACCAGCATTAGCAATGTCCTGTGATTTCT
CATATGAATATCCTCCTTAG
LrhADWL1 GGGAGGCACATTACAAATGGAATTGCTTGTTTGTGTGTGCACAGCATTAACCAGCTCAGTATGACCCGCCAGTAAGTGATAATATGT
GTAGGCTGGAGCTGCTTC
LrhADWL2 CTAAAAAAAAGCCGCTGGGGTTTAAAACACCCCCAGCGGCTCGTTTTTTACACTATTGTCTCAGGAATTATCTATCGTCCGTCGAC
CATATGAATATCCTCCTTAG
LacZDWL1 TTAGGCACCCCAGTCTTTAC ACTCTATGTG TCCGGCTCGT ATGTTGTGTG AAATTGTGAGCGAATAACAATTTCACACAG GATA
CAGCTTTGAGCGATT GTGTAGGCTG GAGCTGCTTC
LacZDWL2 GCGGCGTGAACACCTTATCC GGCCTACGTA GATCTCTGAA ATTGTAGGCC TGATAAGCGG AGCGCATCAGGCAATTTTGC
TTATTTATTAGCCATGGTCCATA TGAATATCCT CCTTAG
The AttB1 and AttB2 sites are underlined. P1 and P2 sites are italicized.
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homology regions. The attB sites are used for a site-spe-
cific BP-recombination reaction with the attP sites of
the pDONR221 vector, using the Gateway
® technology
(Invitrogen). After transformation to CaCl2-competent
E. coli DH5a cells [11], clones were selected on LB
medium containing kanamycin. Kanamycin-resistant
clones were screened by PCR using primers SeqLA1 and
SeqLB, which are flanking the insert on pDONR221.
Plasmid DNA was prepared from sequenced clones,
using the GeneElute™ Plasmid Miniprep Kit (Sigma)
and cut with restriction enzyme PmeI. Subsequently, the
cat gene of plasmid pKD3, flanked by FRT sites, was
amplified with primers P1 and P2 [4] and made blunt
using T4 DNA polymerase. Ligation of the 1034 bp cat
fragment into the PmeI-digested plasmid DNA was per-
formed with the Rapid DNA Ligation Kit (Roche). After
transformation into E. coli DH5a competent cells, trans-
formants were selected on chloramphenicol-containing
LB medium.
Gene replacement using PCR fragments
PCR-fragments carrying both homology regions A and
B, flanking the P1-FRT-cat-FRT-P2 sequence, were
amplified with primers SeqLA1 and SeqLB, using the
pDONR221 clones as template. After purification, about
1 μg of this DNA was introduced by electroporation
(Bio-Rad Gene Pulser apparatus, settings: 25 μFa n d2 . 5
kV; Pulse controller set to 200 Ω)i n t oa r a b i n o s e -
induced E. coli harbouring the Red recombinase system
of Lambda, encoded by the helper plasmid pKD46 [4].
After electroporation, cells were immediately resus-
pended in SOC medium and incubated at 37°C for at
least one hour. After incubation, aliquots were spread
on LB agar plates with chloramphenicol and incubated
at 37°C. Chloramphenicol resistant colonies, that were
kanamycin sensitive, were checked by PCR, using pri-
mers located outside the flanking homology regions A
and B (see Table 1, primers pairs LrhA5/LrhA6, Lac-
ZYA-1/LacZYA-2 or Type1-1/Type1-2), and primers
flanking the cat gene (primers P1 and P2). The transfor-
mants, that became simultaneously chloramphenicol and
kanamycin resistant, were shown to carry the whole
pDONR221-derived template plasmid, present in trace
amounts in the PCR fragments used for electroporation,
instead of an insertion of the cat gene.
Elimination of the antibiotics resistance marker
T h em u t a n t sc a r r yt h es a m eP 1 - F R T - cat-FRT-P2 insert
as in the original Red recombinase-based method [4].
Therefore the cat gene can be easily removed by expres-
sing the FLP recombinase. This FLP, originating from
yeast, recognizes the FRT-sites and mediates a site-speci-
fic recombination, so that the antibiotic resistance gene is
eliminated leaving the same P1-FRT-P2 scar that has no
polar effect on gene expression [4]. The cat gene was
eliminated by use of the temperature sensitive helper
plasmid pCP20 [4], encoding the FLP recombinase.
For this aim, the plasmid PCP20 was introduced by
electroporation in the strain of which the antibiotic resis-
tance marker had to be eliminated. After expression at
28°C for 2 hours, the culture was plated on LB medium
with carbenicilline (100 μg/ml) and incubated overnight
at 28°C. After purification of the colonies on the same
medium, these were purified a second time on LB med-
ium without antibiotics and incubated at 42°C. The
resulting colonies, growing on LB medium but not on LB
with carbenicilline and on LB medium with chloramphe-
nicol, lost the helper plasmid pCP20 and the cat gene.
Original Red-mediated gene targeting method and
modified method, using 85 bp homology regions
PCR-fragments, carrying homology regions flanking the
type 1, lrhA or lac genes and the cat gene of plasmid
pKD3 were purified and about 1 μgo ft h i sD N Aw a s
introduced by electroporation into arabinose-induced E.
coli strains, harbouring pKD46. Primer pairs LrhADW1/
2, LacZDW1/2 and Type1DW1/2 (Table 1) were used
to amplify the regions flanking lrhA, lac and type 1
genes respectively, for the original Red-mediated gene
targeting method [4]. Primer pairs LrhADWL1/2,
LacZDWL1/2 and Type1DWL1/2 (Table 1) were used
to amplify the regions flanking lrhA, lac and type 1
genes respectively, for the Red-mediated gene targeting
method with 85 bp homology regions.
Electroporation for the side-by-side comparison was
carried out into the same batch of arabinose-induced
cells. To test the transformation efficiency of the strains,
the plasmid pEHEC356 was transformed in the same
batch of arabinose-induced E. coli harbouring the Red
recombinase expressing plasmid pKD46.
Phenotypic assays
Motility test of E. coli strains
Motility of the E. coli strains was investigated by transfer-
ring mutant and wild type colonies onto the same plate
containing LB with 0.3% Select agar (Sigma Aldrich) with
a toothpick. After incubation at 30°C for 12-16 hours, the
diameter of the colonies was observed [12].
Agglutination of yeast cells
Adhesion mediated by type 1 fimbriae was tested by
agglutination of commercial baker’s yeast cells (Sacchar-
omyces cerevisiae) on glass slides [13]. Bacteria were
grown statically in LB broth at 37°C for 72 hours. Ali-
quots of washed bacterial suspensions were incubated
with a 2% yeast suspension in PBS and put on a glass
microscope slide. Agglutination was investigated using a
stereomicroscope. As a control, 1% D-mannose (final
concentration) was used to inhibit the agglutination
mediated by type 1 fimbriae.
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Lactose fermentation was tested on MacConkey medium
supplemented with 1% lactose. Lac mutants grow as
white colonies, while wild type Lac
+ colonies are red.
Statement of ethical approval
T h ep r e s e n ts t u d yw a sa p p r o v e db yt h eE t h i c a lC o m -
mittee for Animal Experiments of the Vrije Universi-
teit Brussel (project number 06-219-3) and performed
following all national legislation and institutional
policies.
Results and discussion
Gene replacement in E. coli UTI89
Deletion of the lrhA regulator gene
The LysR-type transcriptional regulator LrhA (LysR
homologue A) controls genes involved in flagellation,
motility and chemotaxis [14]. An lrhA mutant of E.
coli K-12 showed an increased number of flagellae
compared to the wild type. Motility of uropathogenic
E. coli (UPEC) plays an important role in colonization
of the urinary tract [15]. UPEC presumably utilize fla-
gellum-mediated motility during urinary tract infec-
tions to ascend to the upper urinary tract and the
kidneys [16]. The transcriptional regulator LrhA also
regulates the expression of type 1 fimbriae: inactiva-
tion of lrhA in E. coli K - 1 2r e s u l t si na ni n c r e a s e d
expression of type 1 fimbriae and increased biofilm
formation [13].
Deletion of a single functional gene in E. coli UTI89,
by use of the modified Red-mediated gene targeting pro-
cedure, in which 500-600 bp long homology regions
were used to delete genes, was tested by construction of
an UTI89ΔlrhA::Cm
R mutant. The motility of the
UTI89ΔlrhA::Cm
R mutant, in semi-solid LB medium,
was much higher than the motility of wild type UTI89
(see Figure 2). This was expected, because Blumer et al.
[13] reported increased motility of an lrhA mutant of E.
coli MG1655 and UPEC strain 536, due to the increased
number of flagellae per cell.
Type 1 fimbriae of E. coli mediate the adherence to
mannose-containing receptors. Adherence mediated by
fimbriae is important for the virulence of uropathogenic
E. coli (UPEC), and the expression of type 1 fimbriae is
required for colonization of the urinary tract [17,18].
Adhesion, mediated by type 1 fimbriae, was monitored
by the agglutination of yeast cells. The agglutination
caused by the UTI89ΔlrhA::Cm
R mutant was signifi-
cantly stronger, compared to the wild type (data not
shown). Addition of mannose abolished agglutination,
demonstrating that agglutination is mannose-specific
and thus depends on the expression of type 1 fimbriae.
The UTI89ΔlrhA::Cm
R mutant also produced more bio-
film than wild type UTI89 (data not shown). These
results confirm the phenotype of the UTI89ΔlrhA::Cm
R
mutant and show that the described method allows the
site-specific deletion of single genes in the E. coli UTI89
genome.
A side-by-side comparison between the original Red-
mediated gene inactivation method [4], a modified ver-
sion of the original method with longer (85 bp) homol-
ogy regions and the described overlap PCR-based
method using 500-600 bp homology regions was carried
out (See Table 2). UTI89ΔlrhA::Cm
R mutants were
obtained with the three methods.
Deletion of the lac operon
The lac operon, consisting of three adjacent genes (lacZ,
lacY and lacA) is required for the transport and catabo-
lism of lactose in E. coli [19]. UTI89ΔlacZYA::Cm
R
mutants were constructed in the same way as described
for the UTI89ΔlrhA::Cm
R mutant, by use of the modi-
fied Red-mediated gene targeting procedure, in which
500-600 bp long homology regions were used. The pri-
mer pairs AttB1Lac/LacPmeI-1 and LacPmeI-2/Att-
B 2 L a cw e r eu s e dt oa m p l i f yt h eh o m o l o g yr e g i o n s
flanking the lac operon. Finally, 18 out of 20 of the
chloramphenicol resistant UTI89 tranformants were
kanamycin sensitive and produced the expected PCR
fragments. All of these UTI89ΔlacZYA::Cm
R grew as
white colonies on MacConkey medium supplemented
with lactose, while wild type UTI89 produced red colo-
nies. The cat-resistance marker was successfully elimi-
nated by introduction of the pCP20 helper plasmid,
giving rise to UTI89ΔlacZYA.
A comparison between the different methods was car-
ried out (See Table 2). UTI89ΔlacZYA::Cm
R mutants
were obtained with the three methods. As was the case
for the UTI89ΔlrhA::Cm
R mutants, the length of the dif-
ferent homology regions used, seemed not to be the
determining factor for obtaining mutants.
Figure 2 Motility of wild type and lrhA mutant E. coli UTI89
and APEC1. Motility of the E. coli strains was investigated by
transferring mutant and wild type colonies onto the same plate
containing LB with 0.3% agar, with a sterile toothpick. After
incubation, the diameter of the colonies was compared [12]. The
motility of the lrhA mutants is much higher than the motility of the
corresponding wild type strains.
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Adherence of UPEC to the bladder epithelial cells is
mediated by type 1 fimbriae and is crucial to prevent
washout of the pathogenic bacteria by the flow of urine
[17] and for uptake of the bacteria into the bladder
epithelial cells. The type 1 fimbriae of UPEC are
encoded by the fim gene cluster, consisting of nine
genes: fimB, fimE, fimA, fimI, fimC, fimD, fimF, fimG
and fimH. For the construction of the type 1 fimbrial
mutants, primer pairs AttB1Type1/Type1PmeI-1 and
Type1PmeI-2/AttB2Type1 were used to amplify the
homology regions flanking the type1 gene cluster. Two
out of 6 chloramphenicol resistant UTI89 transformants
were kanamycin sensitive and were confirmed by PCR.
These UTI89ΔfimBEAICDFGH::Cm
R mutants did not
agglutinate yeast cells. The cat-resistance marker was
successfully eliminated by introduction of the pCP20
helper plasmid, giving rise to UTI89ΔfimBEAICDFGH.
UTI89ΔfimBEAICDFGH::Cm
R mutants were obtained
with both modified versions of the Red-mediated gene
targeting method, but no mutant was obtained with the
original Red-mediated gene inactivation method (see
Table 2).
Gene replacement in avian pathogenic E. coli
We investigated whether the overlap PCR-based method
was also functional in the avian pathogenic E. coli strain
APEC1 (see Table 2). The APEC1ΔlrhA::Cm
R and APE-
C1ΔlacZYA::Cm
R mutants were successfully constructed
and confirmed by PCR. A motility test with the
APEC1ΔlrhA::Cm
R mutant confirmed that its motility is
much higher than the motility of the wild type APEC1
control (see Figure 2). On MacConkey medium supple-
mented with lactose, APEC1ΔlacZYA::Cm
R mutants
grew as white colonies, while wild type APEC1 produced
red colonies (data not shown). This confirms that the
modified Red-mediated gene targeting method, using
long (500-600 bp) homology regions can also be applied
in this APEC strain. The cat-resistance marker was also
successfully eliminated by introduction of the pCP20
helper plasmid, giving rise to APEC1ΔlacZYA.
Mutants were obtained with both modified versions of
the Red-mediated gene targeting method, but no
mutants were obtained with the original version of the
Red-mediated gene inactivation method Although
APEC1 showed a 5-times higher number of transfor-
mants with the plasmid pEHEC356 than E. coli UTI89,
this did not lead to a 5-times larger number of mutants
than in E. coli UTI89. Therefore, the efficiency of trans-
formation of these strains is not the determining factor
(see Table 2).
We also investigated whether the overlap PCR-based
method was functional in the avian pathogenic E. coli
strains APEC3E, APEC11A and APEC16A (See Table 2).
For APEC3E we only obtained APEC3EΔlrhA::Cm
R by
use of the Red-mediated procedure with 85 bp homol-
ogy regions. No other mutants were found in APEC3E
by any of the other methods. APEC11AΔlrhA::Cm
R
mutants were also only obtained with the Red-mediated
procedure with 85 bp homology regions, an APE-
C11AΔtype1::Cm
R mutant was only obtained with the
original Red-mediated procedure with 50 bp homology
regions and APEC11AΔlacZYA::Cm
R mutants could
only be obtained with the overlap PCR-based procedure
with 500-600 bp long homology regions. For APEC16A,
it was not possible to construct mutants by any of the
three methods used. Nevertheless, transformation of this
strain with plasmid DNA was possible at a low fre-
quency (150 colonies were obtained using 1 ng of plas-
mid pEHEC356 DNA for electroporation). An attempt
to inactivate possible restriction-enzyme activity by heat-
ing at 50°C for 30 min [20] did not lead to any results in
Table 2 Side-by-side comparison between the original and modified Red-mediated gene targeting methods
UTI89 APEC1 APEC3E APEC11A APEC16A
Original Red-mediated gene targeting method
Deletion of type 1 fimbriae cluster 0 0 0 1 0
Deletion of lac operon 2 0 0 0 0
Deletion of lrhA regulator gene 1 0 0 0 0
Modified Red-mediated gene targeting method using 85 bp long homology regions
Deletion of type 1 fimbriae cluster 2 1 0 0 0
Deletion of lac operon 1 4 0 0 0
Deletion of lrhA regulator gene 1 2 2 1 0
Modified Red-mediated gene targeting method using 500-600 bp long homology regions
Deletion of type 1 fimbriae cluster 2 0 0 0 0
Deletion of lac operon 18 2 0 5 0
Deletion of lrhA regulator gene 1 1 0 0 0
The number of chloramphenicol resistant and kanamycin sensitive colonies confirmed by PCR is indicated.
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pEHEC356 transformants to 200 colonies per ng of plas-
mid pEHEC356 DNA.
Conclusions
Methods for disrupting E. coli chromosomal genes,
b a s e do na ne f f i c i e n tm e t h o df o rE. coli K-12 [4] were
tested in clinical UPEC and APEC isolates. Similar Red-
based technology has been successfully used for other
Gram-negative bacteria, like for example Salmonella
[21], Pseudomonas [22], Yersinia [23], Shigella [24] and
Vibrio cholerae [25]. Alterations of the gene disruption
method are occasionally required [22,25,26]. These
approaches mostly rely on the expression of a phage
recombinase in the bacterial strain. We initially found
that deleting specific genes in E. coli UTI89, by the ori-
ginal Red-mediated gene targeting method [4], occurred
at a low and variable frequency and was frequently
unsuccessful. An alternative strategy for constructing
specific mutants, by phage P1-mediated transduction of
insertions from E. coli K-12 to E. coli UTI89, was also
found to be inadequate. The transduction frequency was
invariably low and some experiments were unsuccessful.
In addition, transduction is impossible when genes are
targeted which are not present in the E. coli K-12 gen-
ome. We also noticed that a mutant constructed by
transduction of an insertion from the Keio collection in
E. coli K-12 [12] to UTI89 had a different phenotype
than the mutant constructed in UTI89 by the present
procedure (data not shown). This is presumably due to
the transduction of additional polymorphisms from E.
coli K-12 to UTI89.
We modified the Red-mediated procedure in such a
way that larger regions of homology (500 - 600 bp) were
generated. Our results demonstrate that mutations of
specific genes and also deletions of larger chromosomal
regions, like for example the lac or the type 1 operon in
E. coli UTI89 could be reproducibly obtained. Besides
the deletions reported in the present article, mutations
in 15 other genes were easily obtained at the first
attempt. The method is not only successful in uropatho-
genic E. coli UTI89, but it is also effective in other E.
coli isolates such as the APEC strain APEC1.
When a final side-by-side comparison was made with
the original Red-mediated gene targeting method [4],
using 50 and 85 bp long regions of homology, it was
found that the length of the homology regions is not the
only determining factor for obtaining mutants. In this
experiment, the 500-600 bp long homology method was
not significantly more efficient in E. coli UTI89 and dif-
ferent APEC strains. This again illustrates our observa-
tions on the low reproducibility of Red-mediated gene
targeting in clinical isolates. Although the use of 500-600
bp long homology regions increases the reproducibility of
the method, other factors, possibly the expression level of
the Red proteins at the time of transformation or the effi-
ciency of the electroporation procedure facilitate the tar-
geting in some experiments.
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